Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
基本信息
- 批准号:10456872
- 负责人:
- 金额:$ 46.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:3xTg-AD mouseAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloid beta-ProteinAnimal ModelBacterial InfectionsBindingBone MarrowBrainCASP1 geneCell DeathCellsChronicCognitionCytoplasmic ProteinDataDepositionDevelopmentDiseaseDisease ProgressionEarly Onset Familial Alzheimer&aposs DiseaseEtiologyEventFunctional disorderGenetic RiskGenetic studyGoalsImmuneImmune responseIn VitroInflammagingInflammasomeInflammationInflammatoryInnate Immune ResponseInterleukin ActivationInterleukin-1 betaInterleukin-18Late Onset Alzheimer DiseaseMYD88 deficiencyMeasuresMediatingMicrogliaMolecularMultiprotein ComplexesNerve DegenerationNeuraxisNeurofibrillary TanglesNeuronsPathogenesisPathogenicityPathologicPathologyPathway interactionsPatientsPeripheralPlayPreventivePreventive measureProductionProteinsRiskRoleSenile PlaquesSignal PathwaySignal TransductionSynapsesSystemTherapeuticVirus Diseasesabeta accumulationbrain parenchymacognitive functioncytokinedementia riskextracellularhyperphosphorylated tauin vivomarenostrinmild cognitive impairmentmouse modelneuroinflammationneuron lossprotein complexreconstitutionrisk variantsensorsexsystemic inflammatory responsetau Proteinstau aggregationtau phosphorylation
项目摘要
Project Summary / Abstract
The main pathological changes found in patients with Alzheimer’s disease (AD) are extracellular amyloid β (Aβ)
deposits in the brain parenchyma (amyloid plaques) and abnormal aggregates of hyperphosphorylated tau
protein in brain neurons (neurofibrillary tangles, NFTs). Amyloid plaques and NFTs are accompanied with chronic
inflammation characterized by activated microglia and increased levels of cytokines. Except a small subset of
early-onset familial AD cases, the causes for the vast majority of AD cases are unknown and satisfactory
therapeutic and preventive measures for AD are unavailable. Therefore, an urgent need exists to identify the
molecular mechanisms that increase the risk for the vast majority of AD cases and to develop the preventive and
therapeutic measures. Systemic inflammation promotes AD progression and even initiates microglial activation
and neurodegeneration. Indeed, recent genetic studies on late-onset AD have identified about a dozen genetic
risk variants that are highly expressed in microglia and involved in innate immune responses, highlighting the
importance of immune responses, particularly activated microglia, in the pathogenesis of late-onset AD. Aging
is the largest known risk factor for AD and is characterized by chronic, systemic inflammation (inflamm-aging).
Systemic inflammation caused by certain bacterial and viral infections is a strong risk factor of dementia, also.
Additionally, our preliminary data indicate that activation of NLRP3 inflammasome through the MyD88 signaling
pathway in microglia in the central nervous system (CNS) plays essential roles in the AD pathogenesis. In Aim
1, we will produce a microglia specific MyD88 deficiency in AD mouse models during aging and determine their
effect on Aβ and tau pathology and cognitive function. We further hypothesize that microglial MyD88 signaling
plays a predominant role in accelerating brain Aβ and tau pathology and neuroinflammation, which are induced
by chronic, systemic inflammation, in AD mouse models during aging. In Aim 2, we will determine the effects of
systemic LPS treatment on Aβ and tau pathology and cognition in AD mouse models with brain and peripheral
immune cell-specific MyD88 deficiency. In Aim 3, we will determine the age and sex dependent effects of LPS
treatment on NLRP3 inflammasome activation as disease mechanisms in the brain/microglia-specific and
peripheral immune cell-specific MyD88 deficient AD mouse models. Our hypothesis is that LPS-induced
systemic inflammation causes NLRP3 inflammasome activation in microglia via MyD88 signaling, leading to
exacerbation of AD-like pathophysiology in AD mouse models. The long term goals are to determine the role of
microglial MyD88/NLRP3 inflammasome signaling in the AD pathogenesis, to elucidate the molecular
mechanism underlying the increased AD risk associated with systemic inflammation and to develop new
preventive and therapeutic strategies for AD.
项目总结/摘要
阿尔茨海默病(Alzheimer 'sdisease,AD)患者的主要病理改变是细胞外β淀粉样蛋白(amyloid β,Aβ)
脑实质中的沉积物(淀粉样斑块)和过度磷酸化tau的异常聚集
脑神经元中的蛋白质(神经元缠结,NFT)。淀粉样斑块和NFT伴有慢性
炎症,其特征在于活化的小胶质细胞和增加的细胞因子水平。除了一小部分
早发性家族性AD病例中,绝大多数AD病例的病因未知且令人满意
目前还没有针对AD的治疗和预防措施。因此,迫切需要确定
分子机制,增加了绝大多数AD病例的风险,并制定了预防和
治疗措施。全身炎症促进AD进展,甚至启动小胶质细胞活化
和神经退化事实上,最近对晚发性AD的遗传研究已经确定了大约12种遗传性疾病,
在小胶质细胞中高度表达并参与先天免疫反应的风险变体,突出了
免疫反应(特别是活化的小胶质细胞)在迟发型AD发病机制中的重要性。老化
是AD的最大已知风险因素,其特征在于慢性全身性炎症(炎症-老化)。
由某些细菌和病毒感染引起的全身性炎症也是痴呆症的一个重要危险因素。
此外,我们的初步数据表明,通过MyD 88信号转导激活NLRP 3炎性小体,
中枢神经系统(CNS)小胶质细胞内的信号转导通路在AD发病机制中起重要作用。在Aim中
1,我们将在衰老过程中的AD小鼠模型中产生小胶质细胞特异性MyD 88缺陷,并确定它们的表达。
对Aβ和tau病理学和认知功能的影响。我们进一步假设小胶质细胞MyD 88信号转导
在加速脑Aβ和tau病理学和神经炎症中起主要作用,
慢性全身性炎症,在AD小鼠模型在老化过程中。在目标2中,我们将确定
全身LPS治疗对AD小鼠模型中Aβ和tau病理学和认知的影响
免疫细胞特异性MyD 88缺陷。在目标3中,我们将确定LPS的年龄和性别依赖性效应
治疗作为脑/小胶质细胞特异性疾病机制的NLRP 3炎性小体活化,
外周免疫细胞特异性MyD 88缺陷型AD小鼠模型。我们的假设是LPS诱导的
全身性炎症通过MyD 88信号传导引起小胶质细胞中的NLRP 3炎性小体活化,导致
AD小鼠模型中AD样病理生理学的恶化。长期目标是确定
小胶质细胞MyD 88/NLRP 3炎性体信号转导在AD发病机制中的作用,以阐明AD发病机制的分子机制。
与全身炎症相关的AD风险增加的潜在机制,并开发新的
AD的预防和治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ken-ichiro Fukuchi其他文献
Ken-ichiro Fukuchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ken-ichiro Fukuchi', 18)}}的其他基金
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10314883 - 财政年份:2021
- 资助金额:
$ 46.94万 - 项目类别:
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10611489 - 财政年份:2021
- 资助金额:
$ 46.94万 - 项目类别:
Altering immune tolerance in Alzheimer disease
改变阿尔茨海默病的免疫耐受性
- 批准号:
9979733 - 财政年份:2019
- 资助金额:
$ 46.94万 - 项目类别:
Role of extracellular vesicles in the high-fat diet-induced risk of Alzheimer disease
细胞外囊泡在高脂肪饮食诱发的阿尔茨海默病风险中的作用
- 批准号:
9385535 - 财政年份:2017
- 资助金额:
$ 46.94万 - 项目类别:
Role of diet-induced miR-34a in Alzheimer disease and dementia
饮食诱导的 miR-34a 在阿尔茨海默病和痴呆中的作用
- 批准号:
9225329 - 财政年份:2017
- 资助金额:
$ 46.94万 - 项目类别:
Role of the MyD88-independent pathway in Alzheimers disease
MyD88 独立通路在阿尔茨海默病中的作用
- 批准号:
8511261 - 财政年份:2013
- 资助金额:
$ 46.94万 - 项目类别:
Role of the MyD88-independent pathway in Alzheimers disease
MyD88 独立通路在阿尔茨海默病中的作用
- 批准号:
8676620 - 财政年份:2013
- 资助金额:
$ 46.94万 - 项目类别:
Catalytic and non-catalytic Ig gene delivery for Alzheimer's disease
阿尔茨海默病的催化和非催化 Ig 基因递送
- 批准号:
7963696 - 财政年份:2010
- 资助金额:
$ 46.94万 - 项目类别:
Catalytic and non-catalytic Ig gene delivery for Alzheimer's disease
阿尔茨海默病的催化和非催化 Ig 基因递送
- 批准号:
8081811 - 财政年份:2010
- 资助金额:
$ 46.94万 - 项目类别:
Innate immunity in Alzheimer's disease: Role of toll-like receptor signaling
阿尔茨海默氏病的先天免疫:Toll 样受体信号传导的作用
- 批准号:
7904117 - 财政年份:2009
- 资助金额:
$ 46.94万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 46.94万 - 项目类别:
Operating Grants